NEW YORK, March 19, 2018 /PRNewswire/ —

According to data published by Energias Market Research, the global medical cannabis market is expected to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion in 2024 and at a CAGR of 19.1% from 2018 to 2024. Factors driving the development of the medical cannabis market include increasing recognition of medical benefits, growing demand for cannabis in the treatment of various diseases, and rising number of research and development activities. In the U.S, there are 28 states which have approved the use of cannabis for medical purposes. In major markets like Colorado, California, Alaska, Massachusetts and Nevada, cannabis is legal for recreational use. HQ Global Education Inc. (OTC: HQGE), Hemp, Inc. (OTC: HEMP), CV Sciences, Inc. (OTC: CVSI), Cannabis Sativa, Inc. (OTC: CBDS), Medical Marijuana, Inc. (OTC: MJNA)

Tom Adams, Editor-in-Chief at Arcview Market Research and Principal Analyst at BDS Analytics explained: “Our data shows positive indicators across the board for the legal cannabis industry, in North America and around the globe… The passage of the 2016 ballot initiatives and continued maturation of the existing Adult-Use markets are the primary drivers of the growth this year. That’s nothing compared to what we can expect in 2018 and beyond from Nevada’s tourism, and California and Canada planning to launch Adult-Use sales in 2018.”

HQ Global Education Inc. (OTC: HQGE) on March 13th announced with Hemp, Inc. (OTC: HEMP) that it has signed a consulting agreement with HQ Global Education, Inc. a scientific research development company, to provide consulting services in an effort to help HQ Global Education, Inc. expand into the hemp-CBD industry. According to the agreement, HQGE will receive professional, ongoing, consulting services in the hemp-CBD market, specifically in the areas of growing high quality

Read More Here...